Validation of the Japanese Version of the Pancreatic Exocrine Insufficiency Questionnaire

Psychometric Validation of the Japanese Version of the Pancreatic Exocrine Insufficiency Questionnaire (PEI-Q) - Psychometric Validation of the Japanese Version of the Pancreatic Exocrine Insufficiency Questionnaire (PEI-Q)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000060805

Enrollment

150

Registered

2026-03-02

Start date

2026-03-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic exocrine insufficiency

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients aged 18 years or older with symptoms of PEI within the past 7 days 2) Patients who have provided voluntary written informed consent to participate in this study

Exclusion criteria

Exclusion criteria: 1) Patients with any past or current gastrointestinal disorders 2) Patients with a history of any gastrointestinal surgery within the past 5 years 3) Patients who were considered ineligible for study participation by the principal investigator

Design outcomes

Primary

Measure	Time frame
Discrimination between patients with PEI and healthy adults as assessed by the Japanese version of the PEI-Q	—

Countries

Japan

Contacts

Public ContactRyo Ishii

Viatris Pharmaceuticals Japan G.K. Medical Affairs

ryo.ishii@viatris.com03-5656-0400

Outcome results